文献速递胃肠动力与功能性疾病炎症性肠病

粪便频率的遗传解剖揭示维生素B1代谢及其他可干预通路在肠道动力调节中的作用

Genetic dissection of stool frequency implicates vitamin B1 metabolism and other actionable pathways in the modulation of gut motility.
PubMed 文献 · Gut · 2026-07-08

BACKGROUND: Genetic studies of stool frequency (SF), an indirect proxy for gastrointestinal transit, may reveal therapeutically tractable pathways relevant to IBS and other dysmotility disorders.…

要点

  • 粪便频率遗传力欧洲人7.0%、东亚人5.6%,与胃肠和精神疾病遗传相关(rg=0.18-0.47)。
  • 鉴定21个独立位点,包括胆汁酸合成(KLB)和胆碱能信号(COLQ)等10个新信号。
  • 维生素B1代谢通路关键:SLC35F3和XPR1单变异因果效应,UKB中硫胺素摄入与粪便频率正相关(p<0.0001)。

核心结论

  • 研究识别了肠道动力控制的可治疗机制,包括维生素B1此前未被认识的作用。
  • 这些发现值得开展机制和临床研究以评估其在IBS和其他动力障碍综合征中的转化潜力。

研究设计与样本

  • 估计遗传力和遗传相关性,使用孟德尔随机化检验因果关系。
  • 对GWAS信号进行精细定位和功能注释,优先候选基因和通路。

主要发现

  • 粪便频率遗传力在欧洲人(7.0%)和东亚人(5.6%)中相当。
  • 与胃肠和精神疾病强遗传相关(rg=0.18-0.47),对IBS有因果效应。
  • 与心血管性状新遗传相关(rg=0.12-0.14),得到药物特征富集分析支持。
  • 鉴定21个独立位点,包括10个新信号涉及胆汁酸合成(KLB)和胆碱能信号(COLQ)。
  • 精细定位聚焦维生素B1代谢,SLC35F3和XPR1单变异因果效应显著。

临床怎么用

  • 提示维生素B1代谢通路可能作为调节肠道动力的干预靶点,但需进一步机制和临床研究验证。
  • 遗传发现涉及胆汁酸合成和胆碱能信号,可能为IBS和动力障碍提供新治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genetic studies of stool frequency (SF), an indirect proxy for gastrointestinal transit, may reveal therapeutically tractable pathways relevant to IBS and other dysmotility disorders. OBJECTIVE: To identify genes and mechanisms involved in gut motility, providing a foundation for clinical translation. DESIGN: We performed a multiancestry genome-wide association study (GWAS) meta-analysis of SF in 268 606 European and East Asian individuals. Heritability and genetic correlations with other traits were estimated, and Mendelian randomisation was used to test causal relationships. GWAS signals were fine-mapped and functionally annotated to prioritise candidate genes and pathways. Findings implicating thiamine metabolism were followed-up with dietary interaction analyses in UK Biobank (UKB). RESULTS: SF heritability was comparable in Europeans (7.0%) and East Asians (5.6%). We observed strong genetic correlations with gastrointestinal and psychiatric disorders (rg=0.18-0.47), and causal effects on IBS. Novel correlations with cardiovascular traits (rg=0.12-0.14) were supported by drug signature enrichment analyses. We identified 21 independent loci, including 10 novel signals implicating bile acid synthesis (KLB) and cholinergic signalling (COLQ). Fine-mapping converged on vitamin B1 metabolism, highlighting single-variant causal effects at SLC35F3 (a thiamine transporter) and XPR1 (phosphate exporter essential for thiamine activation). In 98 449 UKB participants, thiamine intake was positively associated with SF (p<0.0001), and a combined SLC35F3/XPR1 genotype score significantly modulated this effect (p<0.0001). CONCLUSIONS: We identify therapeutically tractable mechanisms involved in the control of gut motility, including a previously unrecognised role for vitamin B1. These findings warrant mechanistic and clinical studies to evaluate their translational potential in IBS and other dysmotility syndromes.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Díaz-Muñoz C, Bozzarelli I, Lopera-Maya EA, et al. Genetic dissection of stool frequency implicates vitamin B1 metabolism and other actionable pathways in the modulation of gut motility. Gut. 2026. PMID: 41558814. doi:10.1136/gutjnl-2025-337059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。